![Ofir Moreno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ofir Moreno worked as a Senior Director-Chemistry at Dendreon Corp.
from 2003 to 2007.
He then worked at MEI Pharma, Inc. from 2010 to 2022, where he held the position of Senior Vice President-Pharmaceutical Sciences from 2019 to 2022.
Moreno holds a doctorate degree from Harvard University and an undergraduate degree from Cornell University.
Anciens postes connus de Ofir Moreno
| Sociétés | Poste | Fin |
|---|---|---|
| LITE STRATEGY, INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 |
| DENDREON CORPORATION | Corporate Officer/Principal | 01/11/2007 |
Formation de Ofir Moreno
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
